Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:collaboratesWith |
gptkb:Amgen
gptkb:Bristol_Myers_Squibb |
| gptkbp:developedBy |
gptkb:BridgeBio_Pharma
gptkb:MD_Anderson_Cancer_Center |
| https://www.w3.org/2000/01/rdf-schema#label |
BBP-398
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
SHP2 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:studiedIn |
gptkb:non-small_cell_lung_cancer
solid tumors KRAS-mutant cancers |
| gptkbp:target |
gptkb:SHP2
|
| gptkbp:bfsParent |
gptkb:LianBio
|
| gptkbp:bfsLayer |
7
|